BridgeBio Pharma (BBIO) PT Raised to $115 at Piper Sandler as 'Attruby Outperforms'
Tweet Send to a Friend
(Updated - August 11, 2026 9:54 AM EDT)
Piper Sandler analyst Biren Amin raised the price target on BridgeBio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Biren Amin raised the price target on BridgeBio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
